In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance

Journal of Infection and Chemotherapy

Volumn 9, Issue 3, 2003, Pages 221-226

  Ubukata, Kimiko ^a   Iwata, Satoshi ^b   Sunakawa, Keisuke ^a  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

ErmB gene; Macrolide antibiotic resistance; mefA gene; Streptococcus pneumoniae; Telithromycin

Indexed keywords

AZITHROMYCIN; CEFOTAXIME; CLARITHROMYCIN; CLINDAMYCIN; JOSAMYCIN; KETOLIDE; MACROLIDE; MIDECAMYCIN; PENICILLIN G; ROKITAMYCIN; ROXITHROMYCIN; TELITHROMYCIN;

AGAR GEL DIFFUSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MENINGITIS; BACTERIUM ISOLATION; CONTROLLED STUDY; ERMB GENE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MEFA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OTITIS MEDIA; PBP1A GENE; PBP2B GENE; PBP2X GENE; PENICILLIN RESISTANCE; PNEUMONIA; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0142026531     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0258-2     Document Type: Article

References (38)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
2. Nelson CT, Mason EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
3. Shortridge VD, Flamm RK, Ramer N, Beyer J, Tanaka SK. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbial Infect Dis 1996;26:73-8.
4. Ubukata K, Asahi Y, Okuzumi K, Konno M, and the working Group for penicillin-resistant Streptococcus pneumoniae. Incidence of penicillin-resistant Streptococcus pneumoniae in Japan. 1993-1995, J Infect Chemother 1995;2:177-84.
5. Johnston NJ, Azavedo DE JC, Kellner JD, Low E. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998;42:2425-6.
6. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996;40:2526-6.
7. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolide but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996;40:1817-24.
8. Trieu-Cuot P, Poyart-Salmeron C, Carlier C, Courvalin P. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res 1990;18:3660.
9. Tait-Komradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L, Yuan W, et al. mefA is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997;471:2251-5.
10. Clancy J, Petitpas J, Dib-Haji F, Yuan W, Cronan M, Kamath AV, et al. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 1996;22:867-79.
11. Ubukata K, Muraki T, Igarashi A, Asahi Y, Konno M, and the working Group for penicillin-resistant Streptococcus pneumoniae. In vitro evaluation of the activity of beta-lactams, new quinolones, and other antimicrobial agents against Streptococcus pneumoniae. J Infect Chemother 1996;2:213-21.
12. Bryskier A, Agouridas C, Chantot Ketolides J-F. New semisynthetic 14-membered-ring macrolides. In: Zinner SH, Young LS, Acar JF, Neu HC, editors. Expanding indications for the new macrolides, azalides, and streptogramins. New York: Marcel Dekker; 1997. p. 39-50.
13. Jones R, Biedenbach D. Antimicrobial activity of RU-66647, a new ketolide. Diagn Microbiol Infect Dis 1997;27:7-12.
14. Reinert RR, Bryskier A, Lutticken R. In vitro activities of the new ketolide antibiotics HMR3004 and HMR3647 against Streptococcus pneumoniae in Germany. Antimicrob Agents Chemother 1998;42:1509-11.
15. Rosato A, Vicarini H, Bonnefoy A, Chantot JF, Leclercq R. A new ketolide, HMR3004, active against streptococci induciby resistant to erythromycin. Antimicrob Agents Chemother 1998;42:1392-6.
16. Ubukata K, Asahi Y, Yamane Y, Konno M. Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbiol 1996;40:1257-9.
17. Ubukata K, Muraki T, Igarashi A, Asahi Y, Konno M. Identification of penicillin and other beta-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. J Infect Chemother 1997;3:190-7.
18. Horinouchi S, Weisblum B. Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc Natl Acad Sci USA 1980;77:7079-83.
19. Martin B, Alloing G, Mejean V, Claverys JP. Constitutive expression of erythromycin resistance mediated by the ermAM determinant of plasmid pAMb1 results from deletion of 5′ leader peptide sequences. Plasmid 1987;18:250-3.
20. Show JH, Clewell DB. Complete nucleotide sequence of macrolide-licosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J Bacteriol 1985;164:782-96.
21. Asahi Y, Ubukata K. Association of Thr371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998;42:2267-73.
22. Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991;35:1267-72.
23. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995;39:577-85.
24. Lai CJ, Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci USA 1971;68:856-60.
25. Murphy E. Nucleotide sequence of ermA, a macrolide-lincosamide-streptogramin B determinant in Staphylococcus aureus. J Bacteriol 1985;162:633-40.
26. Thakker-Varia S, Jenssen WD, Moon-ML, Weinstein MP, Dubin DT. Molecular epidemiology of macrolides-licosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother 1987;31:735-43.
27. Dubnau D, Monod M. The regulation and evolution of MLS resistance. Banbury Rep 1986;24:369-86.
28. Eady EA, Ross JI, Tipper JL, Walters CE, Cove JH, Noble WC. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother 1993;31:211-7.
29. Gryczan T, Grandi G, Hahn J, Crandi R, Dubnau D. Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance. Nucleic Acids Res 1980;8:6081-97.
30. Horinouchi S, Woo-Hyeon B, Weisblum B. A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis. J Bacteriol 1983;154:1252-62.
31. Goldman RC, Capobianco JO. Role of an energy-dependent efflux pump in plasmid pNE24 mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother 1990;34:1973-80.
32. Lampson BC, Von David W, Parisi JT. Novel mechanism for plasmid-mediated erythromycin reisistance by pNE24 from Staphylococcus epidermidis. Antimicrob. Agents Chemother 1986;30:653-8.
33. Ross JI, Farrell AM, Eady EA, Cove JH, Cunliffe WJ. Characterization and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother 1989;24:851-62.
34. Ross JI, Eady EA, Cove JH, Cunliffe WJ, Baumberg S, Wootton JC. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol 1990;4:1207-14.
35. Ross JI, Eady EA, Cove JH, Baumberg S. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter msrA may interact. Gene 1995;153:93-8.
36. Ross JI, Eady EA, Cove JH, Baumberg S. Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene 1996;183:143-8.
37. Wondrack L, Massa M, Yang BV, Sutcliffe J. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother 1996;40:992-8.
38. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999;43:2823-30.